Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the obesity paradox by body mass index and waist circumference in patients undergoing percutaneous coronary intervention.
Shirahama Y, Tabata N, Sakamoto K, Sato R, Yamanaga K, Fujisue K, Sueta D, Araki S, Takashio S, Arima Y, Hokimoto S, Sato K, Sakamoto T, Nakao K, Shimomura H, Matsumura T, Tayama S, Fujimoto K, Oshima S, Nakamura S, Tsunoda R, Hirose T, Kikuta K, Sakaino N, Yamamoto N, Kajiwara I, Suzuki S, Yamamoto E, Kaikita K, Matsushita K, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators. Shirahama Y, et al. Among authors: yamamoto n, yamamoto e. Int J Obes (Lond). 2022 Oct;46(10):1840-1848. doi: 10.1038/s41366-022-01163-7. Epub 2022 Jul 28. Int J Obes (Lond). 2022. PMID: 35902692
Effects of perindopril on aldosterone production in the failing human heart.
Mizuno Y, Yasue H, Yoshimura M, Fujii H, Yamamoto N, Nakayama M, Harada E, Sakamoto T, Nakamura S, Ito T, Shimasaki Y, Ogawa H, Saito Y, Nakao K. Mizuno Y, et al. Among authors: yamamoto n. Am J Cardiol. 2002 May 15;89(10):1197-200. doi: 10.1016/s0002-9149(02)02304-4. Am J Cardiol. 2002. PMID: 12008175 Clinical Trial.
Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease.
Sakamoto T, Ogawa H, Nakao K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Canderstan for Prevention of Cardiovascular Events after CYPHER or TAXUS Coronary Stenting) investigators. Sakamoto T, et al. Among authors: yamamoto n. J Atheroscler Thromb. 2013;20(5):472-80. doi: 10.5551/jat.13870. Epub 2013 Mar 14. J Atheroscler Thromb. 2013. PMID: 23411616 Free article. Clinical Trial.
Clinical outcomes of percutaneous coronary intervention (PCI) at hospital with or without onsite cardiac surgery backup.
Akasaka T, Hokimoto S, Oshima S, Nakao K, Fujimoto K, Miyao Y, Shimomura H, Tsunoda R, Hirose T, Kajiwara I, Matsumura T, Nakamura N, Yamamoto N, Koide S, Oka H, Morikami Y, Sakaino N, Kaikita K, Nakamura S, Matsui K, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators. Akasaka T, et al. Among authors: yamamoto n. Int J Cardiol. 2014 Oct 20;176(3):1385-7. doi: 10.1016/j.ijcard.2014.08.027. Epub 2014 Aug 10. Int J Cardiol. 2014. PMID: 25156861 No abstract available.
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Ono T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS study investigators. Tsujita K, et al. Among authors: yamamoto n. J Cardiol. 2015 Oct;66(4):353-8. doi: 10.1016/j.jjcc.2014.12.011. Epub 2015 Jan 7. J Cardiol. 2015. PMID: 25577723 Free article. Clinical Trial.
Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation　- The Kumamoto Intervention Conference Study (KICS) Registry.
Ishii M, Hokimoto S, Akasaka T, Fujimoto K, Miyao Y, Kaikita K, Oshima S, Nakao K, Shimomura H, Tsunoda R, Hirose T, Kajiwara I, Matsumura T, Nakamura N, Yamamoto N, Koide S, Oka H, Morikami Y, Sakaino N, Matsui K, Ogawa H; Kumamoto Intervention Conference Study (KICS) Investigators. Ishii M, et al. Among authors: yamamoto n. Circ J. 2015;79(5):1115-24. doi: 10.1253/circj.CJ-14-0789. Epub 2015 Feb 24. Circ J. 2015. PMID: 25739954 Free article.
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators. Tsujita K, et al. Among authors: yamamoto n. J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065. J Am Coll Cardiol. 2015. PMID: 26227186 Free article. Clinical Trial.
Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
Sakamoto T, Ogawa H, Nakao K, Hokimoto S, Tsujita K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Candesartan for Prevention of Cardiovascular Events after CYPHER™ or TAXUS™ Coronary Stenting) study investigators. Sakamoto T, et al. Among authors: yamamoto n. J Cardiol. 2016 Apr;67(4):371-7. doi: 10.1016/j.jjcc.2015.06.009. Epub 2015 Aug 4. J Cardiol. 2016. PMID: 26254019 Free article. Clinical Trial.
6,253 results